We provide you with 20 years of free, institutional-grade data for XAIR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of XAIR. Explore the full financial landscape of XAIR stock.
| Reported Date | CIK | Ticker | Type |
|---|
Beyond Air, Inc(NASDAQ:XAIR) 
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops inhaled nitric oxide (NO) to treat respiratory infections, and gaseous NO to treat solid tumors. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the...
Website: http://www.beyondair.net
Founded: 2011
Full Time Employees: 23
CEO: Steven A. Lisi
Sector: Healthcare
Industry: Medical Devices
Share this website to your friends
The information provided in this report about XAIR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.